Cliff Asness's STOK Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 46,459 shares of Stoke Therapeutics, Inc. (STOK) worth $1.51 M, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 7 quarters.
Based on 13F filings, Cliff Asness has maintained this position in STOK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 41,971 shares. Largest reduction occurred in Q4 2024, reducing 51,470 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Stoke Therapeutics (STOK) Holding Value Over Time
Track share changes against reported price movement
Quarterly Stoke Therapeutics (STOK) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +16,992 | Add 57.66% | 46,459 | $32.56 |
| Q4 2025 | +354 | Add 1.22% | 29,467 | $31.74 |
| Q3 2025 | -25,705 | Reduce 46.89% | 29,113 | $23.50 |
| Q2 2025 | +41,971 | Add 326.70% | 54,818 | $11.35 |
| Q1 2025 | -10,772 | Reduce 45.61% | 12,847 | $6.65 |
| Q4 2024 | -51,470 | Reduce 68.55% | 23,619 | $11.03 |
| Q3 2024 | +75,089 | New Buy | 75,089 | $12.29 |
Cliff Asness's Stoke Therapeutics Investment FAQs
Cliff Asness first purchased Stoke Therapeutics, Inc. (STOK) in Q3 2024, acquiring 75,089 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Stoke Therapeutics, Inc. (STOK) for 7 quarters since Q3 2024.
Cliff Asness's largest addition to Stoke Therapeutics, Inc. (STOK) was in Q3 2024, adding 75,089 shares worth $922,843.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 46,459 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $1.51 M.
As of the Q1 2026 filing, Stoke Therapeutics, Inc. (STOK) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Stoke Therapeutics, Inc. (STOK) was 75,089 shares, as reported at the end of Q3 2024.